1,3-dipropyl-8-cyclopentylxanthine has been researched along with n(6)-cyclopentyladenosine in 152 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.66) | 18.7374 |
1990's | 68 (44.74) | 18.2507 |
2000's | 68 (44.74) | 29.6817 |
2010's | 15 (9.87) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ijzerman, AP; Soudijn, W; van der Wenden, EM | 1 |
Ishii, A; Nonaka, H; Shimada, J; Suzuki, F | 1 |
Jacobson, KA; van Galen, PJ; Williams, M | 1 |
Jacobson, MA; Johnson, RG; Linden, J; Salvatore, CA; Taylor, HE | 1 |
Fredholm, BB; Hegler, J; Hessling, J; Klotz, KN; Kull, B; Lohse, MJ; Owman, C | 1 |
Barbhaiya, H; IJzerman, AP; Rivkees, SA | 1 |
Hess, S; Hölzl, J; Khudeir, N; Müller, CE; Scholle, S; Schumacher, B | 1 |
de Ligt, RA; IJzerman, AP; Leurs, R; Lorenzen, A; Rivkees, SA | 1 |
Beukers, MW; Brussee, J; Chang, LC; Ijzerman, AP; Mulder-Krieger, T; Roerink, SF; Spanjersberg, RF; van den Hout, G; von Frijtag Drabbe Künzel, JK | 1 |
Brussee, J; Chang, LC; Ijzerman, AP; Mulder-Krieger, T; Spangenberg, T; von Frijtag Drabbe Künzel, JK; Westerhout, J | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Beukers, MW; Brussee, J; Chang, LC; IJzerman, AP; Mulder-Krieger, T; Struensee-Link, R; van Veldhoven, JP; von Frijtag Drabbe Künzel, JK | 1 |
Beukers, MW; Brussee, J; de Graaf, O; de Vries, H; Göblyös, A; Ijzerman, AP; Link, R; Mantri, M; Mulder-Krieger, T; van Veldhoven, J; von Frijtag Drabbe Künzel, JK | 1 |
Cappellacci, L; Franchetti, P; Grifantini, M; Kachler, S; Klotz, KN; Lavecchia, A; Luongo, L; Maione, S; Marabese, I; Petrelli, R; Vita, P | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
El-Tayeb, A; Inamdar, GS; Li, W; Müller, CE; Scheiff, AB; Sudarsanam, V; Vasu, KK; Yerande, SG | 1 |
Federico, S; Jacobson, KA; Jayasekara, PS; Kozma, E; Moro, S; Paoletta, S; Spalluto, G; Squarcialupi, L | 1 |
Terre'Blanche, G; Van der Walt, MM | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Cox, BF; Lappe, RW; Merkel, LA; Perrone, MH; Rivera, LM | 1 |
Brink, A; Fuder, H; Meincke, M; Tauber, U | 1 |
Földes, FF; Nagano, O; Nakatsuka, H; Ohta, Y; Reich, D; Sperlagh, B; Vizi, ES | 1 |
O'Regan, MH; Perkins, LM; Phillis, JW; Simpson, RE | 1 |
Herzer, WA; Jackson, EK; Kuan, CJ | 1 |
IJzerman, AP; Jacobson, KA; Van Galen, PJ | 1 |
Domenici, MR; Frank, C; Sagratella, S; Scotti de Carolis, A; Zeng, YC | 1 |
Czernilofsky, A; Dumont, JE; Ensinger, HA; Lefort, A; Libert, F; Mendla, KD; Van Sande, J; Vassart, G | 1 |
Hourani, SM; Kitchen, I; Nicholls, J | 1 |
Barraco, RA; Phillis, JW | 1 |
Barraco, RA; Normile, HJ | 1 |
Lothman, EW; Stringer, JL | 1 |
Badger, EW; Bristol, JA; Bruns, RF; Fergus, JH; Hartman, JD; Hays, SJ; Huang, CC; Santay, LA | 1 |
Starke, K; Stoffel, D; von Kügelgen, I | 1 |
Imaizumi, M; Miyazaki, S; Onodera, K | 1 |
Apaya, RP; IJzerman, AP; Price, SL; Soudijn, W; van der Wenden, EM | 1 |
Späth, L; Starke, K; von Kügelgen, I | 1 |
Martin, PL; Potts, AA | 1 |
Carter, M; Jacobson, KA; Ji, XD; Paul, IA; Von Lubitz, DK | 1 |
Alexander, SP; Hill, SJ; Iredale, PA | 1 |
Broad, RM; Cook, MA | 1 |
Carter, M; Jacobson, KA; Paul, IA; Von Lubitz, DK | 1 |
Joad, JP; Kott, KS | 1 |
Bruns, RF; Montamat, SC; Mudumbi, RV; Vestal, RE | 1 |
Halfhide, EJ; Hourani, SM; Kitchen, I; Lee, BS; Nicholls, J | 1 |
Hill, SJ; Peakman, MC | 1 |
Dickenson, JM; Hill, SJ; Megson, AC; Townsend-Nicholson, A | 1 |
Broad, RM; Fredholm, BB | 1 |
Brownhill, VR; Hourani, SM; Kitchen, I | 3 |
Berger, M; Christoffel, F; Gebicke-Haerter, PJ; Northoff, H; Timmer, J; Van Calker, D | 1 |
Gonçalves, J; Queiroz, G | 1 |
Jackson, EK; Kusaka, H; Pfeifer, CA; Tofovic, SP | 1 |
Andrés, A; Fernández, M; Ros, M; Sanz, JM; Vendite, D | 1 |
Hettinger-Smith, BD; Leid, M; Murray, TF | 1 |
Brownhill, VR; Hourani, SM; Kitchen, I; Peachey, JA | 1 |
Abe, T; Gutterman, DD; Morgan, DA | 1 |
Guimarães, S; Moura, D; Vaz-da-Silva, MJ | 1 |
Gupta, YK; Malhotra, J | 2 |
Cooke, MJ; Fisher, A; Fraser, CM; Stone, TW; Thompson, ID | 2 |
Berger, M; Biber, K; Gebicke-Härter, PJ; Klotz, KN; van Calker, D | 1 |
Koch, H; Starke, K; von Kügelgen, I | 1 |
Coffey, D; Cronstein, BN; Fisher, R; Lahita, RG; Merrill, JT; Salmon, J; Schreibman, D; Shen, C; Zakharenko, O | 1 |
Chopde, CT; Ghosh, AK; Mandhane, SN | 1 |
Antal, K; Cseppentö, A; Kovács, P; Szabó, JZ; Szentmiklósi, AJ; Ujfalusi, A | 1 |
Buxton, IL; Cheek, DJ; Smith, AD; Westfall, DP | 1 |
Hourani, SM; Nicholls, J | 1 |
Fulga, I; Stone, TW | 1 |
Amanatullah, DF; Clair, T; Liotta, LA; Schetz, JA; Stracke, ML; Woodhouse, EC | 1 |
Hettinger, BD; Leid, M; Murray, TF | 1 |
Bockaert, J; Manzoni, O; Pujalte, D; Williams, J | 1 |
Han, DH; Hansen, PA; Holloszy, JO; Nolte, LA | 1 |
Beukers, MW; Dalpiaz, A; IJzerman, AP; Schofield, PR; Townsend-Nicholson, A | 1 |
Chessell, IP; Dowd, E; Humphrey, PP; McQueen, DS | 1 |
Hourani, SM; Kitchen, I; Peachey, JA | 1 |
Coupar, IM | 1 |
Cattarini, G; Florio, T; Maragliano, A; Schettini, G; Thellung, S | 1 |
IJzerman, AP; Kourounakis, AP; van der Klein, PA | 1 |
Davis, JM; Gute, DC; Jones, S; Korthuis, RJ; Krsmanovic, A | 1 |
Cunha, RA; Lopes, LV; Ribeiro, JA | 1 |
Costentin, J; El Yacoubi, M; Ledent, C; Parmentier, M; Vaugeois, JM | 1 |
Agostinho, P; Caseiro, P; Cunha, RA; Duarte, EP; Oliveira, CR; Rego, AC | 1 |
Fain, JN; Rice, AM; Rivkees, SA | 1 |
Jacks, SM; Kapicka, CL; Montamat, SC; Mudumbi, RV; Olson, RD; Vestal, RE | 1 |
Materi, LM; Rasmusson, DD; Semba, K | 1 |
Dickenson, JM; Germack, R | 1 |
Brand, A; Eschke, D; Nieber, K; Vissiennon, Z | 1 |
Koos, BJ; Maeda, T | 1 |
Barrière, H; Bidet, M; Cuiller, B; Poujeol, C; Poujeol, P; Rubera, I; Tauc, M; Verheecke-Mauze, C | 1 |
Cunha, RA; de Mendonça, A; Ribeiro, JA; Sebastião, AM | 1 |
Allgaier, C; Brand, A; Eger, K; Eschke, D; Hess, S; Nieber, K; Scheibler, P | 1 |
Dickenson, JM; Robinson, AJ | 1 |
Hancox, JC; Hinde, AK; Zhang, YH | 1 |
Matsumoto, K; Murakami, Y; Tabata, K; Watanabe, H | 1 |
Blauth, E; Cassel, JC; Feuerstein, TJ; Jackisch, R; Kelche, C; Sehmisch, S; Thorn, D | 1 |
Nakata, H; Saitoh, O; Yoshioka, K | 1 |
Jan, C; Koos, BJ; Maeda, T | 1 |
Coupar, IM; Tran, BL | 1 |
Brooke, RE; Deuchars, J; Deuchars, SA | 1 |
Biondi, C; Dalpiaz, A; Forni, F; Pavan, B; Scatturin, A; Vandelli, MA | 1 |
Dar, MS | 1 |
Hamann, M; Richter, A | 1 |
Cheng, JT; Chi, TC; Liu, IM | 1 |
Ben-Ari, Y; Dzhala, V; Khalilov, I; Khazipov, R | 1 |
Allen, CN; Honda, K; Ikeda, M; Inoué, S; Sagara, M; Sekino, Y; Shirao, T; Yoshioka, T | 1 |
Dai, LJ; Kang, HS; Kerstan, D; Quamme, GA; Ritchie, G | 1 |
Furue, H; Kumamoto, E; Lao, LJ; Luo, C; Yoshimura, M | 1 |
Battastini, AM; Bonan, CD; Choi, H; Izquierdo, I; Mello e Souza, T; Pereira, GS; Rodrigues, C; Sarkis, JJ; Vinadé, ER | 1 |
Allescher, HD; Dunkel, R; Schusdziarra, V; Storr, M; Thammer, J | 1 |
Antoniou, K; Ferré, S; Fuxe, K; Goldberg, SR; Justinova, Z; Karcz-Kubicha, M; Müller, CE; Pezzola, A; Popoli, P; Quarta, D; Reggio, R; Solinas, M; Terasmaa, A | 1 |
Burki, N; Gu, Q; Hong, JL; Lee, LY; Ruan, T | 1 |
Coelho, JE; Costenla, AR; Cunha, RA; de Mendonça, A; Lopes, LV; Oliveira, CR; Parada, A; Rebola, N; Soares-da-Silva, P | 1 |
Christie, MJ; Hack, SP; Vaughan, CW | 1 |
Battastini, AM; Bonan, CD; Crema, L; da Silva Torres, IL; Dalmaz, C; De Leon Nunes, M; Ferreira, MB; Sarkis, JJ | 1 |
Goulart, EC; Kaster, MP; Rodrigues, AL; Rosa, AO; Rosso, MM; Santos, AR | 1 |
Nowak, TS; Sorimachi, T | 1 |
Avsar, E; Empson, RM | 1 |
Fujita, T; Kawasaki, Y; Kumamoto, E; Liu, T | 1 |
de Ligt, RA; IJzerman, AP; Klaasse, E; Leurs, R; Lorenzen, A; Milligan, G; Roerink, SF | 1 |
Goto, W; Hirao, M; Ikeda, T; Kobayashi, T; Oku, H; Sugiyama, T | 1 |
Cao, Y; Jin, L; Meng, F; Sun, WC; Wang, LZ; Zhu, XZ | 1 |
Higa, K; Higuchi, H; Iihoshi, M; Nitahara, K; Shono, S; Vizi, ES | 1 |
Bonan, CD; Cammarota, M; Izquierdo, I; Pereira, GS; Rossato, JI; Sarkis, JJ | 1 |
Kogi, K; Konno, T; Nagai, A; Nakahata, N; Uchibori, T | 1 |
Beukers, MW; de Grip, WJ; Ijzerman, AP; Klaasse, EC; Roerink, SF; van den Hout, G | 1 |
Cao, C; Han, JH; Kim, SH; Kim, SZ; Yuan, K | 1 |
Dalpiaz, A; Heitman, LH; IJzerman, AP; Mulder-Krieger, T; Spanjersberg, RF; von Frijtag Drabbe Künzel, JK | 1 |
Cao, Y; Jin, L; Sun, WC; Xie, KQ; Zhu, XZ | 1 |
Cao, Y; Xie, KQ; Zhu, XZ | 1 |
Kubota, Y; Kunitomo, M; Mizuno, H; Morikawa, T; Nakamura, K; Shinozuka, K; Tanaka, N | 1 |
Bonen, A; Dyck, DJ; Graham, TE; Greer, F; Lally, JS; Thong, FS | 1 |
Fewell, JE; Gillis, AM; Zhang, C | 1 |
Cunha-Reis, D; Ribeiro, JA; Sebastião, AM | 1 |
Inoue, K; Miyazaki, N; Nakatsuka, T; Nohda, K; Takeda, D; Yoshida, M | 1 |
Kelty, JD; Shields, EJ; Vandam, RJ | 1 |
Almeida, RS; Carrettiero, DC; Fior-Chadi, DR | 1 |
Kaczynska, K; Szereda-Przestaszewska, M | 1 |
Church, JE; Coupar, IM; Pouton, CW; Rose'Meyer, RB; Urmaliya, VB; White, PJ | 1 |
Bertram, EH; Hargus, NJ; Patel, MK | 1 |
Inscho, EW; Osmond, DA | 1 |
Cui, Y; Gong, QJ; Li, YY; Liu, CC; Liu, XG; Liu, Y; Wang, J; Wei, XH; Xin, WJ | 1 |
Ledent, C; Pouton, CW; Short, JL; Urmaliya, VB; White, PJ | 1 |
Cechova, S; Elsobky, AM; Venton, BJ | 1 |
Albensi, BC; Parkinson, FE; Xiong, W; Zhang, D | 1 |
Atas, HC; Biber, K; Normann, C; Serchov, T; van Calker, D | 1 |
Golab, F; Katebi, M; Mehdizadeh, M; Mohamadzadeh, F; Soleimani, M; Zamani, M | 1 |
Cascalheira, JF; Sebastião, AM; Serpa, A | 1 |
Nascimento, F; Ribeiro, JA; Sebastião, AM | 1 |
Kumei, S; Miyagishi, S; Nozu, T; Ohhira, M; Okumura, T; Takakusaki, K | 1 |
Dastjerdi, MN; Mardani, M; Ra, MZ; Valiani, A | 1 |
2 review(s) available for 1,3-dipropyl-8-cyclopentylxanthine and n(6)-cyclopentyladenosine
Article | Year |
---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
Fluorescent ligands for adenosine receptors.
Topics: Boron Compounds; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Ligands; Protein Binding; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1 | 2013 |
150 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and n(6)-cyclopentyladenosine
Article | Year |
---|---|
A steric and electrostatic comparison of three models for the agonist/antagonist binding site on the adenosine A1 receptor.
Topics: Adenosine; Binding Sites; Chemical Phenomena; Chemistry, Physical; Electrochemistry; Models, Molecular; Molecular Conformation; Molecular Structure; Purinergic Antagonists; Receptors, Purinergic; Regression Analysis; Structure-Activity Relationship; Xanthine; Xanthines | 1992 |
8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Cell Membrane; Corpus Striatum; Guinea Pigs; Humans; Molecular Conformation; Molecular Structure; Prosencephalon; Purinergic Antagonists; Rats; Receptors, Purinergic; Stereoisomerism; Structure-Activity Relationship; Xanthines | 1992 |
Molecular cloning and characterization of the human A3 adenosine receptor.
Topics: Adenosine; Amino Acid Sequence; Animals; Binding, Competitive; CHO Cells; Cloning, Molecular; Consensus Sequence; Corpus Striatum; Cricetinae; DNA Primers; Gene Expression; Humans; Iodobenzenes; Kinetics; Liver; Lung; Molecular Sequence Data; Polymerase Chain Reaction; Rats; Receptors, Purinergic P1; Sequence Homology, Amino Acid; Sheep; Transfection | 1993 |
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Base Composition; Binding, Competitive; CHO Cells; Cricetinae; Guanylate Cyclase; Humans; Phenethylamines; Phenylisopropyladenosine; Receptors, Purinergic P1; Stereoisomerism; Structure-Activity Relationship; Transfection; Xanthines | 1998 |
Identification of the adenine binding site of the human A1 adenosine receptor.
Topics: Adenine; Amides; Amino Acid Sequence; Amino Acids; Binding Sites; DNA, Complementary; Humans; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Receptors, Purinergic P1 | 1999 |
Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors.
Topics: Animals; CHO Cells; Cricetinae; Cyclic AMP; GABA-A Receptor Antagonists; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Lignans; Plant Roots; Purinergic P1 Receptor Agonists; Rats; Serotonin Antagonists; Valerian | 2002 |
A "locked-on," constitutively active mutant of the adenosine A1 receptor.
Topics: Adenosine; Animals; Binding, Competitive; Cell Line; Cell Membrane; Chlorocebus aethiops; Colforsin; COS Cells; Cyclic AMP; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Humans; Kinetics; Mutation; Plasmids; Radioligand Assay; Receptor, Adenosine A1; Sodium; Sulfur Radioisotopes; Theophylline; Thiophenes; Transfection; Tritium; Xanthines | 2005 |
A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.
Topics: Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Aminopyridines; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dioxoles; Ligands; Models, Molecular; Radioligand Assay; Structure-Activity Relationship | 2005 |
2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Imidazoles; Pyridines; Radioligand Assay; Structure-Activity Relationship | 2007 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.
Topics: Amines; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Receptor, Adenosine A1; Receptor, Adenosine A2A; Structure-Activity Relationship | 2008 |
2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Topics: Adenosine A2 Receptor Antagonists; Amines; Animals; Cell Line; Cricetinae; Cyclic AMP; Furans; Humans; Models, Molecular; Molecular Structure; Nicotinic Acids; Nitriles; Receptor, Adenosine A2A; Structure-Activity Relationship | 2008 |
N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenylyl Cyclases; Analgesics; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclopentanes; Humans; Mice; Models, Molecular; Norbornanes; Pain Measurement; Radioligand Assay; Stereoisomerism; Structure-Activity Relationship | 2009 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Topics: Adenosine A1 Receptor Antagonists; Animals; Drug Design; Humans; Molecular Structure; Rats; Receptor, Adenosine A1; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2010 |
1,3,7-Triethyl-substituted xanthines--possess nanomolar affinity for the adenosine A1 receptor.
Topics: Adenosine A1 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Molecular Structure; Protein Binding; Receptor, Adenosine A1; Structure-Activity Relationship; Xanthines | 2015 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.
Topics: Adenosine; Animals; Brain; Coronary Vessels; Cyclic GMP; In Vitro Techniques; Nitric Oxide; Potassium; Potassium Channels; Rats; Receptors, Purinergic; Swine; Vasodilator Agents; Xanthines | 1992 |
Purinoceptor-mediated modulation by endogenous and exogenous agonists of stimulation-evoked [3H]noradrenaline release on rat iris.
Topics: Adenosine; Animals; Electric Stimulation; In Vitro Techniques; Iris; Male; Norepinephrine; Pyrazines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Synaptic Transmission; Theophylline; Xanthines | 1992 |
Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation.
Topics: 2-Chloroadenosine; Acetylcholine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Diaphragm; Dipyridamole; Electric Stimulation; In Vitro Techniques; Magnesium; Male; Mice; Muscle Contraction; Neuromuscular Junction; Phrenic Nerve; Purinergic Antagonists; Receptors, Purinergic; Synapses; Synaptic Transmission; Theophylline; Tritium; Tubocurarine; Xanthines | 1992 |
Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Aspartic Acid; Brain Ischemia; Cerebral Cortex; Glutamates; Glutamic Acid; Male; Neurotransmitter Agents; Purinergic Antagonists; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Triazoles; Xanthines | 1992 |
An experimental paradigm for investigating the role of endogenous adenosine/A1 receptor interactions in vivo.
Topics: Adenosine; Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Male; Phenethylamines; Purinergic Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Stereoisomerism; Xanthines | 1992 |
Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor.
Topics: Adenosine; Amino Acid Sequence; Animals; Bacteriorhodopsins; Dogs; GTP-Binding Proteins; Histidine; Ligands; Models, Chemical; Models, Molecular; Molecular Sequence Data; Protein Binding; Receptors, Purinergic; Xanthines | 1992 |
Effects of adenosinergic drugs on hypoxia-induced electrophysiological changes in rat hippocampal slices.
Topics: Adenosine; Animals; Caffeine; Dizocilpine Maleate; Electrophysiology; Hippocampus; Hypoxia; In Vitro Techniques; Male; Membrane Potentials; Phenethylamines; Phenylisopropyladenosine; Potassium; Purinergic Antagonists; Rats; Rats, Inbred Strains; Synapses; Xanthines | 1992 |
Cloning and functional characterization of a human A1 adenosine receptor.
Topics: Adenosine; Amino Acid Sequence; Animals; Base Sequence; CHO Cells; Cloning, Molecular; Colforsin; Cricetinae; DNA; DNA Probes; Dogs; Hippocampus; Humans; Molecular Sequence Data; Nucleic Acid Hybridization; Receptors, Purinergic; Sequence Homology, Nucleic Acid; Transfection; Xanthines | 1992 |
Characterization of P1-purinoceptors on rat duodenum and urinary bladder.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Duodenum; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Phenethylamines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Urinary Bladder; Vasodilator Agents; Xanthines | 1992 |
Subtypes of adenosine receptors in the brainstem mediate opposite blood pressure responses.
Topics: Adenosine; Animals; Antihypertensive Agents; Blood Pressure; Brain Stem; Dose-Response Relationship, Drug; Male; Phenethylamines; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Triazoles; Xanthines | 1991 |
N6-cyclopentyladenosine impairs passive avoidance retention by selective action at A1 receptors.
Topics: Adenosine; Animals; Avoidance Learning; Drug Interactions; Electroshock; Male; Memory; Mice; Receptors, Purinergic; Time Factors; Water Deprivation; Xanthines | 1991 |
A1 adenosinergic modulation alters the duration of maximal dentate activation.
Topics: 2-Chloroadenosine; Adenosine; Animals; Electric Stimulation; Hippocampus; Limbic System; Male; Rats; Rats, Inbred Strains; Receptors, Purinergic; Seizures; Time Factors; Xanthines | 1990 |
Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.
Topics: Adenosine; Animals; Brain; Cell Membrane; Female; Kinetics; Nucleosides; Rats; Xanthines | 1987 |
P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antihypertensive Agents; Atropine; Desipramine; Dose-Response Relationship, Drug; Electric Stimulation; Heart Atria; Indomethacin; Male; Norepinephrine; Phenethylamines; Protein Synthesis Inhibitors; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Receptors, Purinergic P2; Suramin; Triazines; Xanthines; Yohimbine | 1995 |
Effects of xanthine derivatives in a light/dark test in mice and the contribution of adenosine receptors.
Topics: Adenosine; Animals; Antihypertensive Agents; Anxiety; Behavior, Animal; Caffeine; Darkness; Drug Interactions; Light; Male; Mice; Phenethylamines; Purinergic P1 Receptor Antagonists; Structure-Activity Relationship; Theophylline; Xanthines | 1994 |
Relative binding orientations of adenosine A1 receptor ligands--a test case for Distributed Multipole Analysis in medicinal chemistry.
Topics: Adenosine; Computer Graphics; Drug Design; Electrochemistry; Kinetics; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theophylline; Xanthines | 1995 |
Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.
Topics: Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Cerebral Cortex; Male; Norepinephrine; Rats; Rats, Wistar; Receptors, Purinergic P1; Receptors, Purinergic P2; Tetrodotoxin; Xanthines; Yohimbine | 1994 |
The endothelium of the rat renal artery plays an obligatory role in A2 adenosine receptor-mediated relaxation induced by 5'-N-ethylcarboxamidoadenosine and N6-cyclopentyladenosine.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Arginine; Endothelium, Vascular; Glyburide; In Vitro Techniques; Indomethacin; Isoproterenol; Male; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Renal Artery; Renal Circulation; Theophylline; Vasodilator Agents; Xanthines | 1994 |
Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice.
Topics: Adenosine; Animals; Binding Sites; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Receptors, Purinergic P1; Seizures; Xanthines | 1994 |
Coupling of a transfected human brain A1 adenosine receptor in CHO-K1 cells to calcium mobilisation via a pertussis toxin-sensitive mechanism.
Topics: Adenosine; Animals; Brain; Calcium; CHO Cells; Cricetinae; GTP-Binding Proteins; Humans; Pertussis Toxin; Receptors, Purinergic P1; Transfection; Virulence Factors, Bordetella; Xanthines | 1994 |
Inhibition of neurotransmitter release from enteric nerve endings by 2-[p-(carboxyethyl)-phenethylamino]-5'-N-ethylcarboxamido-adenosine (CGS-21680) and related adenosine analogs: lack of simple competition by antagonists.
Topics: Adenosine; Animals; Female; Guinea Pigs; In Vitro Techniques; Male; Myenteric Plexus; Neurotransmitter Agents; Phenethylamines; Purinergic Antagonists; Receptors, Purinergic; Xanthines | 1993 |
Effects of N6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice.
Topics: Adenosine; Animals; Drug Interactions; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Seizures; Survival Rate; Temperature; Xanthines | 1993 |
Effect of adenosine receptor ligands on cAMP content in human airways and peripheral lung.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adolescent; Adult; Aged; Child; Cromolyn Sodium; Cyclic AMP; Female; Humans; Ligands; Lung; Male; Middle Aged; Phenethylamines; Receptors, Purinergic; Respiratory System; Theophylline; Xanthines | 1993 |
Cardiac functional responses to adenosine by PD 81,723, an allosteric enhancer of the adenosine A1 receptor.
Topics: Adenosine; Allosteric Regulation; Animals; Atrial Function; Depression, Chemical; Drug Synergism; Heart; Heart Atria; Heart Rate; Male; Myocardial Contraction; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Theophylline; Thiophenes; Xanthines | 1993 |
Characterization and ontogeny of P1-purinoceptors on rat vas deferens.
Topics: Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Aging; Animals; Animals, Newborn; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Muscle Development; Muscle, Smooth; Norepinephrine; Rats; Rats, Wistar; Receptors, Purinergic; Tetrodotoxin; Vas Deferens; Vasodilator Agents; Xanthines | 1993 |
Adenosine A1 receptor-mediated changes in basal and histamine-stimulated levels of intracellular calcium in primary rat astrocytes.
Topics: Adenosine; Animals; Animals, Newborn; Astrocytes; Calcium; Cells, Cultured; Histamine; Histamine Agonists; Image Processing, Computer-Assisted; Rats; Rats, Wistar; Receptors, Histamine H1; Receptors, Purinergic P1; Xanthines | 1995 |
Synergy between the inositol phosphate responses to transfected human adenosine A1-receptors and constitutive P2-purinoceptors in CHO-K1 cells.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Cattle; Cells, Cultured; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Humans; Inositol Phosphates; Pertussis Toxin; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Agonists; Uridine Triphosphate; Virulence Factors, Bordetella; Xanthines | 1995 |
A1, but not A2A, adenosine receptors modulate electrically stimulated [14C]acetylcholine release from rat cortex.
Topics: 2-Chloroadenosine; Acetylcholine; Adenosine; Animals; Cerebral Cortex; Electric Stimulation; In Vitro Techniques; Male; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Xanthines | 1996 |
Selective enhancement by an adenosine A1 receptor agonist of agents inducing contraction of the rat vas deferens.
Topics: Adenosine; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Bradykinin; Carbachol; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Phenylephrine; Potassium Chloride; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Serotonin; Tyramine; Vas Deferens; Xanthines | 1996 |
Differential distribution of adenosine A2 receptors in the epididymal and prostatic portions of the rat vas deferens.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Dose-Response Relationship, Drug; Drug Interactions; Male; Rats; Rats, Wistar; Receptors, Purinergic P1; Vas Deferens; Xanthines | 1996 |
Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Animals, Newborn; Cell Division; Cells, Cultured; Microglia; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; Thymidine; Xanthines | 1996 |
Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors.
Topics: Adenosine; Adenosine Deaminase; Adenosine Triphosphate; Animals; Arteries; Male; Norepinephrine; Phenethylamines; Rats; Rats, Wistar; Receptors, Purinergic; Tail; Thioinosine; Thionucleotides; Xanthines | 1996 |
Central effects of caffeine on renal renin secretion and norepinephrine spillover.
Topics: Adenosine; Animals; Caffeine; Central Nervous System Stimulants; Hydralazine; Injections, Intraventricular; Kidney; Male; Norepinephrine; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Renin; Vasodilator Agents; Xanthines | 1996 |
Adenosine A1 receptors in cultured cerebellar granule cells: role of endogenous adenosine.
Topics: Adenosine; Adenosine Deaminase; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclases; Animals; Animals, Newborn; Cell Membrane; Cells, Cultured; Cerebellum; Colforsin; Cyclic AMP; GTP-Binding Proteins; Kinetics; Neurons; Phenylisopropyladenosine; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Time Factors; Xanthines | 1996 |
Chronic exposure to adenosine receptor agonists and antagonists reciprocally regulates the A1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells.
Topics: 2-Chloroadenosine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adenylyl Cyclases; Animals; Binding, Competitive; Cell Membrane; Cerebellum; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Kinetics; Neurons; Phenylisopropyladenosine; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Theophylline; Time Factors; Xanthines | 1996 |
The ontogenetic profiles of the pre- and postjunctional adenosine receptors in the rat vas deferens.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Age Factors; Animals; Animals, Suckling; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Development; Muscle, Smooth; Neuroeffector Junction; Rats; Rats, Wistar; Receptors, Purinergic P1; Vas Deferens; Xanthines | 1996 |
Differential ontogeny of adenosine receptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Duodenum; Intestinal Mucosa; Male; Muscle Development; Muscle Relaxation; Muscle, Smooth; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 1996 |
Role of adenosine receptor subtypes in neural stunning of sympathetic coronary innervation.
Topics: Adenosine; Animals; Coronary Vessels; Dogs; Female; Male; Myocardial Stunning; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Sympathetic Nervous System; Theobromine; Theophylline; Vasoconstriction; Xanthines | 1997 |
Adenosine and the endothelium-dependent modulation of 3H-noradrenaline release in the canine pulmonary artery.
Topics: Adenosine; Animals; Dogs; Electric Stimulation; Endothelin-1; Endothelium, Vascular; Female; Isotope Labeling; Male; Neuromuscular Junction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Potassium; Potassium Channels; Pulmonary Artery; Purinergic P1 Receptor Antagonists; Suramin; Tetraethylammonium; Tetraethylammonium Compounds; Tritium; Xanthines | 1995 |
Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats.
Topics: Adenosine; Animals; Blood Pressure; Body Temperature; Heart Rate; Male; Pentylenetetrazole; Rats; Rats, Wistar; Receptors, Purinergic P1; Seizures; Xanthines | 1997 |
Purine modulation of dizocilpine effects on spontaneous alternation.
Topics: Adenosine; Animals; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Male; Maze Learning; Memory; Mice; Muscarinic Antagonists; Receptors, Purinergic P1; Scopolamine; Xanthines | 1997 |
Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression.
Topics: Adenosine; Adenylate Cyclase Toxin; Adrenergic alpha-Agonists; Animals; Astrocytes; Brain; Cells, Cultured; Cyclic AMP; Enzyme Activation; Excitatory Amino Acid Antagonists; Extracellular Space; Glutamates; Inositol Phosphates; Intercellular Signaling Peptides and Proteins; Peptides; Rats; Receptors, Adrenergic, alpha; Receptors, Purinergic P1; RNA, Messenger; Type C Phospholipases; Virulence Factors, Bordetella; Wasp Venoms; Xanthines | 1997 |
P2-receptor-mediated inhibition of noradrenaline release in the rat hippocampus.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Electric Stimulation; Hippocampus; In Vitro Techniques; Isotope Labeling; Male; Norepinephrine; Phenethylamines; Rats; Rats, Wistar; Receptors, Purinergic P2; Thionucleotides; Triazines; Tritium; Xanthines; Yohimbine | 1997 |
Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis.
Topics: Adenosine; Antirheumatic Agents; Arthritis, Rheumatoid; Cells, Cultured; Humans; Methotrexate; Monocytes; Receptors, Purinergic P1; Rheumatoid Nodule; Tetradecanoylphorbol Acetate; Theobromine; Xanthines | 1997 |
Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Catalepsy; Dopamine Antagonists; Haloperidol; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Scopolamine; Theobromine; Theophylline; Xanthines | 1997 |
Regulation of purinoceptors in guinea pig pulmonary artery: functional evidences.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Female; Guinea Pigs; Pulmonary Artery; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic; Vasoconstriction; Vasodilation; Xanthines | 1996 |
Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.
Topics: 2-Chloroadenosine; Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding Sites; Binding, Competitive; In Vitro Techniques; Kinetics; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Vas Deferens; Xanthines | 1997 |
The involvement of adenosine receptors in the effect of dizocilpine on mice in the elevated plus-maze.
Topics: Adenosine; Animals; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Mice; Motor Activity; Receptors, N-Methyl-D-Aspartate; Receptors, Purinergic P1; Xanthines | 1997 |
Characterization of adenosine receptors on rat ileum, ileal longitudinal muscle and muscularis mucosae.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Electric Stimulation; Ileum; Intestinal Mucosa; Male; Muscle, Smooth; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Vasodilator Agents; Xanthines | 1997 |
Comparison of an adenosine A1 receptor agonist and antagonist on the rat EEG.
Topics: Adenosine; Animals; Electroencephalography; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Xanthines | 1998 |
Adenosine receptor mediates motility in human melanoma cells.
Topics: Adenosine; Adenosine Monophosphate; Animals; Chemotaxis; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Melanoma, Experimental; Pertussis Toxin; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Transfection; Virulence Factors, Bordetella; Xanthines | 1998 |
Cyclopentyladenosine-induced homologous down-regulation of A1 adenosine receptors (A1AR) in intact neurons is accompanied by receptor sequestration but not a reduction in A1AR mRNA expression or G protein alpha-subunit content.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Cells, Cultured; Cerebellum; Down-Regulation; Gene Expression; GTP-Binding Protein alpha Subunits, Gs; Neurons; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; RNA, Messenger; Theophylline; Tritium; Xanthines | 1998 |
Decreased presynaptic sensitivity to adenosine after cocaine withdrawal.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Affinity Labels; Animals; Cocaine; Dipyridamole; Dopamine Uptake Inhibitors; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; Male; Nucleus Accumbens; Phosphodiesterase Inhibitors; Presynaptic Terminals; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Substance Withdrawal Syndrome; Substance-Related Disorders; Theophylline; Thioinosine; Vasodilator Agents; Xanthines | 1998 |
Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions.
Topics: Adenosine; Adenosine Deaminase; Adenylyl Cyclase Inhibitors; Animals; Biological Transport; Cyclic AMP; Drug Synergism; Glucose; Glucose Transporter Type 4; Insulin; Male; Monosaccharide Transport Proteins; Muscle Contraction; Muscle Proteins; Muscle, Skeletal; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 1998 |
Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.
Topics: Adenosine; Alanine; Amino Acid Substitution; Animals; Binding, Competitive; CHO Cells; Cricetinae; Entropy; Humans; Kinetics; Point Mutation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptors, Purinergic P1; Theophylline; Thermodynamics; Threonine; Transfection; Xanthines | 1998 |
Adenosine A1 receptor-mediated excitation of nociceptive afferents innervating the normal and arthritic rat knee joint.
Topics: Action Potentials; Adenosine; Adenosine Triphosphate; Analgesics; Animals; Arthritis, Experimental; Hypolipidemic Agents; Knee Joint; Male; Neurons, Afferent; Nociceptors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 1998 |
Ontogeny of adenosine receptors in the longitudinal muscle and muscularis mucosae of the rat distal colon.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Aging; Animals; Autoradiography; Binding Sites; Binding, Competitive; Colon; Male; Muscle Contraction; Muscle Development; Muscle, Smooth; Radioligand Assay; Rats; Rats, Wistar; Receptors, Purinergic P1; Subcellular Fractions; Vasodilator Agents; Xanthines | 1999 |
Characterization and tissue location of the neural adenosine receptor in the rat ileum.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Animals; Female; Ileum; Male; Neurons; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 1999 |
Effect of adenosinergic modulation on the anticonvulsant effect of phenobarbitone and carbamazepine.
Topics: Adenosine; Animals; Anticonvulsants; Carbamazepine; Convulsants; Drug Combinations; Male; Pentylenetetrazole; Phenobarbital; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Seizures; Theophylline; Xanthines | 1999 |
Polydeoxyribonucleotides enhance the proliferation of human skin fibroblasts: involvement of A2 purinergic receptor subtypes.
Topics: Adenosine; Calcium; Cell Division; Cytophotometry; Deoxyribonucleosides; Deoxyribonucleotides; Fibroblasts; Fura-2; Humans; Oligodeoxyribonucleotides; Placenta; Receptors, Purinergic P1; Second Messenger Systems; Theobromine; Xanthines | 1999 |
Allosteric modulation of the adenosine A(1) receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding.
Topics: Adenosine; Allosteric Regulation; Animals; Binding, Competitive; Brain; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Thiophenes; Xanthines | 1999 |
Ischemic preconditioning prevents postischemic P-selectin expression in the rat small intestine.
Topics: Adenosine; Adenosine Deaminase; Animals; Antibodies, Monoclonal; Ischemia; Ischemic Preconditioning; Jejunum; Male; Organ Specificity; P-Selectin; Protein Kinase C; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Reperfusion; Theobromine; Xanthines | 1999 |
Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Aging; Animals; Binding, Competitive; Cerebral Cortex; Electrophysiology; Hippocampus; In Vitro Techniques; Male; Phenethylamines; Protein Kinase C; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptor Cross-Talk; Receptor, Adenosine A2A; Receptors, Purinergic P1; Synaptic Membranes; Triazines; Triazoles; Xanthines | 1999 |
The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists.
Topics: Adenosine; Administration, Oral; Animals; Anxiety; Behavior, Animal; Caffeine; Darkness; Drug Administration Schedule; Injections, Intraperitoneal; Light; Male; Maze Learning; Mice; Mice, Knockout; Neuroprotective Agents; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Reaction Time; Receptor, Adenosine A2A; Triazines; Triazoles; Xanthines | 2000 |
Adenosine modulation of D-[3H]aspartate release in cultured retina cells exposed to oxidative stress.
Topics: Adenosine; Adenosine Deaminase; Animals; Ascorbic Acid; Aspartic Acid; Calcium; Cells, Cultured; Chick Embryo; Drug Synergism; Kinetics; Oxidative Stress; Phenethylamines; Potassium; Potassium Chloride; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; Retina; Theobromine; Tritium; Xanthines | 2000 |
A1 adenosine receptor activation increases adipocyte leptin secretion.
Topics: Adenosine; Adipocytes; Animals; Culture Techniques; Dipyridamole; Gene Expression; Leptin; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; RNA, Messenger; Xanthines | 2000 |
Effects of cyclopentyladenosine on isoproterenol response in adult and senescent cardiac tissue from Fischer 344 rats.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adrenergic beta-Agonists; Aging; Animals; Cardiotonic Agents; Electric Stimulation; Heart; Heart Atria; Heart Ventricles; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Myocardium; Purinergic P1 Receptor Agonists; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, Adrenergic, beta; Xanthines | 2000 |
Inhibition of synaptically evoked cortical acetylcholine release by adenosine: an in vivo microdialysis study in the rat.
Topics: Acetylcholine; Adenosine; Analysis of Variance; Animals; Caffeine; Cerebral Cortex; Chromatography, High Pressure Liquid; Dipyridamole; Male; Microdialysis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Synapses; Xanthines | 2000 |
Activation of protein kinase B by the A(1)-adenosine receptor in DDT(1)MF-2 cells.
Topics: Adenosine; Androstadienes; Animals; Calcium; Cell Line; Chromones; Cricetinae; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Genistein; Imidazoles; Indoles; Insulin; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Morpholines; Pertussis Toxin; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyridines; Receptors, Purinergic P1; Virulence Factors, Bordetella; Wortmannin; Xanthines | 2000 |
Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons.
Topics: Adenosine; Animals; Cerebral Cortex; Drug Interactions; Electric Stimulation; Female; In Vitro Techniques; Male; Neurons; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Receptor, Adenosine A3; Receptors, Purinergic P1; Synaptic Transmission; Triazoles; Xanthines | 2001 |
Adenosine A(2A) receptors mediate cardiovascular responses to hypoxia in fetal sheep.
Topics: Adenosine; Animals; Blood Gas Analysis; Blood Pressure; Female; Fetal Hypoxia; Heart Rate; Hydrogen-Ion Concentration; Phenethylamines; Pregnancy; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; Sheep; Triazines; Triazoles; Xanthines | 2001 |
Extracellular adenosine modulates a volume-sensitive-like chloride conductance in immortalized rabbit DC1 cells.
Topics: Adenosine; Animals; Cell Line; Cell Membrane; Cell Size; Chloride Channels; Gadolinium; Guanosine 5'-O-(3-Thiotriphosphate); Hypotonic Solutions; Iodine Radioisotopes; Kidney Tubules; Lanthanum; Manganese; Membrane Potentials; Patch-Clamp Techniques; Rabbits; Receptors, Purinergic P1; Recombinant Proteins; Transfection; Xanthines | 2001 |
Modification of adenosine modulation of synaptic transmission in the hippocampus of aged rats.
Topics: Adenosine; Adenosine Deaminase; Aging; Animals; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Hippocampus; Hypoxia; In Vitro Techniques; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Synaptic Transmission; Xanthines | 2000 |
Effect of an adenosine A(1) receptor agonist and a novel pyrimidoindole on membrane properties and neurotransmitter release in rat cortical and hippocampal neurons.
Topics: Adenosine; Animals; Hippocampus; In Vitro Techniques; Indoles; Male; Membrane Potentials; Neurons; Neurotransmitter Agents; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Somatosensory Cortex; Xanthines | 2001 |
Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.
Topics: Adenosine; Animals; Cell Line; Cricetinae; Enzyme Inhibitors; Hypoglycemic Agents; Insulin; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Protein Kinase C; Protein-Tyrosine Kinases; Receptors, Purinergic P1; Signal Transduction; Vasodilator Agents; Xanthines | 2001 |
Anti-adrenergic effect of adenosine on Na(+)-Ca(2+) exchange current recorded from guinea-pig ventricular myocytes.
Topics: Adenosine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carbachol; Cells, Cultured; Cholinergic Agonists; GTP-Binding Protein alpha Subunits, Gi-Go; Guinea Pigs; Heart Ventricles; Isoproterenol; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Protein Kinase C; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Adrenergic, beta; Receptors, Purinergic P1; Signal Transduction; Sodium-Calcium Exchanger; Ventricular Function; Xanthines | 2001 |
Ameliorative effects of paeoniflorin, a major constituent of peony root, on adenosine A1 receptor-mediated impairment of passive avoidance performance and long-term potentiation in the hippocampus.
Topics: Adenosine; Animals; Avoidance Learning; Benzoates; Bridged-Ring Compounds; Glucosides; Hippocampus; Long-Term Potentiation; Male; Mice; Monoterpenes; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 2001 |
Electrically evoked release of glutamate in rat hippocampal slices: effects of various drugs and fimbria-fornix lesions.
Topics: Action Potentials; Adenosine; Animals; Electric Stimulation; Fornix, Brain; Glutamic Acid; Hippocampus; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 2001 |
Heteromeric association creates a P2Y-like adenosine receptor.
Topics: Adenosine; Adenylyl Cyclases; Animals; Cell Line; Cell Membrane; Cyclic AMP; GTP-Binding Protein alpha Subunits, Gi-Go; Heterotrimeric GTP-Binding Proteins; Humans; Inositol 1,4,5-Trisphosphate; Kinetics; Macromolecular Substances; Purinergic P1 Receptor Agonists; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Purinergic P1; Receptors, Purinergic P2; Recombinant Proteins; Transfection; Tritium; Xanthines | 2001 |
Adenosine A(1) and A(2A) receptors modulate sleep state and breathing in fetal sheep.
Topics: Adenosine; Animals; Fetus; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Respiratory Physiological Phenomena; Sheep; Sleep Stages; Triazines; Triazoles; Xanthines | 2001 |
Withdrawal and bidirectional cross-withdrawal responses in rats treated with adenosine agonists and morphine.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Female; Injections, Subcutaneous; Male; Morphine; Morphine Dependence; Muscle Contraction; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Theobromine; Xanthines | 2001 |
Adenosine A1 receptors reduce release from excitatory but not inhibitory synaptic inputs onto lateral horn neurons.
Topics: Adenosine; Animals; Antibody Specificity; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Immunohistochemistry; In Vitro Techniques; Interneurons; Male; Microscopy, Electron; Neural Inhibition; Patch-Clamp Techniques; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Reaction Time; Receptors, Purinergic P1; Spinal Cord; Sympathetic Nervous System; Synapses; Synaptic Transmission; Thorax; Xanthines | 2001 |
Poly(lactic acid) microspheres for the sustained release of a selective A1 receptor agonist.
Topics: Adenosine; Cyclic AMP; Delayed-Action Preparations; Drug Stability; Humans; Lactic Acid; Microspheres; Polyesters; Polymers; Purinergic P1 Receptor Agonists; Xanthines | 2001 |
Modulation of ethanol-induced motor incoordination by mouse striatal A(1) adenosinergic receptor.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Affinity Labels; Animals; Antihypertensive Agents; Ataxia; Azides; Benzodiazepines; Central Nervous System Depressants; Corpus Striatum; Ethanol; Male; Mice; Mice, Inbred ICR; Microinjections; Motor Activity; Pertussis Toxin; Phenethylamines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Vasodilator Agents; Virulence Factors, Bordetella; Xanthines | 2001 |
Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia.
Topics: Adenosine; Animals; Caffeine; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Dystonia; Female; Male; Mesocricetus; Muscle Contraction; Mutation; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Theobromine; Theophylline; Triazines; Triazoles; Xanthines | 2001 |
Activation of adenosine A1 receptors by drugs to lower plasma glucose in streptozotocin-induced diabetic rats.
Topics: Adenosine; Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Dipyridamole; Disease Models, Animal; Dose-Response Relationship, Drug; Glucose; Glycogen; Hypoglycemic Agents; Insulin; Male; Muscle, Skeletal; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Streptozocin; Theophylline; Triglycerides; Xanthines | 2000 |
Neuronal mechanisms of the anoxia-induced network oscillations in the rat hippocampus in vitro.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Adenosine; Anesthetics, Local; Animals; Bicuculline; Diazepam; Excitatory Amino Acid Antagonists; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Hippocampus; Hypoxia, Brain; In Vitro Techniques; Male; Membrane Potentials; Neurons; Patch-Clamp Techniques; Periodicity; Potassium; Rats; Rats, Wistar; Tetrodotoxin; Xanthines | 2001 |
The sulphydryl reagent, N-ethylmaleimide, disrupts sleep and blocks A1 adenosine receptor-mediated inhibition of intracellular calcium signaling in the in vitro ventromedial preoptic nucleus.
Topics: Adenosine; Animals; Body Temperature; Calcium; Calcium Channels; Calcium Signaling; Circadian Rhythm; Ethylmaleimide; Fura-2; Glutamic Acid; GTP-Binding Proteins; Hypothalamus; Immunohistochemistry; Male; Neurons; Potassium; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Second Messenger Systems; Sleep; Sulfhydryl Reagents; Tetrodotoxin; Xanthines | 2001 |
Adenosine modulates Mg(2+) uptake in distal convoluted tubule cells via A(1) and A(2) purinoceptors.
Topics: Adenosine; Adenosine Triphosphate; Aldosterone; Animals; Calcium; Cell Line, Transformed; Cyclic AMP; Enzyme Inhibitors; Ion Transport; Kidney Tubules, Distal; Magnesium; Mice; Parathyroid Hormone; Phenethylamines; Protein Kinase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theobromine; Xanthines | 2001 |
Adenosine inhibits excitatory transmission to substantia gelatinosa neurons of the adult rat spinal cord through the activation of presynaptic A(1) adenosine receptor.
Topics: Adenosine; Age Factors; Analgesics; Animals; Antihypertensive Agents; Excitatory Postsynaptic Potentials; In Vitro Techniques; Male; Neural Inhibition; Neurons; Patch-Clamp Techniques; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Substantia Gelatinosa; Triazines; Triazoles; Xanthines | 2001 |
Blockade of adenosine A1 receptors in the posterior cingulate cortex facilitates memory in rats.
Topics: Adenosine; Animals; Avoidance Learning; Dose-Response Relationship, Drug; Gyrus Cinguli; Male; Memory; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; Retention, Psychology; Xanthines | 2002 |
Modulatory effect of adenosine receptors on the ascending and descending neural reflex responses of rat ileum.
Topics: Adenosine; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Flavins; Gastrointestinal Motility; Ileum; In Vitro Techniques; Male; Muscarinic Antagonists; Muscle Contraction; Neural Inhibition; Neurons; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Reflex; Tetrodotoxin; Xanthines | 2002 |
Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.
Topics: Adenosine; Amphetamine; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Male; Motor Activity; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Theophylline; Time Factors; Triazines; Triazoles; Tritium; Xanthines | 2003 |
Hypersensitivity of pulmonary C fibers induced by adenosine in anesthetized rats.
Topics: Adenosine; Anesthesia; Animals; Body Weight; Bradycardia; Bronchial Hyperreactivity; Capsaicin; Dose-Response Relationship, Drug; Infusions, Intravenous; Lung; Male; Nerve Fibers, Unmyelinated; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Purinergic P1; Xanthines | 2003 |
Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats.
Topics: Adenosine; Adenosine Triphosphate; Animals; Blotting, Western; Electrophysiology; Excitatory Postsynaptic Potentials; Hippocampus; Immunohistochemistry; Kindling, Neurologic; Long-Term Potentiation; Male; Neuroprotective Agents; Organ Culture Techniques; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Synaptic Transmission; Synaptosomes; Xanthines | 2003 |
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.
Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines | 2003 |
Effect of drugs active at adenosine receptors upon chronic stress-induced hyperalgesia in rats.
Topics: Adenosine; Animals; Chronic Disease; Hyperalgesia; Male; Pain Measurement; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Stress, Physiological; Xanthines | 2003 |
Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors.
Topics: Adenosine; Animals; Antidepressive Agents; Caffeine; Depressive Disorder; Disease Models, Animal; Female; Male; Mice; Motor Activity; Receptor, Adenosine A1; Receptor, Adenosine A2A; Stress, Psychological; Triazines; Triazoles; Xanthines | 2004 |
Pharmacological manipulations of ATP-dependent potassium channels and adenosine A1 receptors do not impact hippocampal ischemic preconditioning in vivo: evidence in a highly quantitative gerbil model.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Female; Gerbillinae; Glyburide; Hippocampus; Ischemic Preconditioning; Membrane Potentials; Potassium Channels; Receptor, Adenosine A1; Xanthines | 2004 |
Adenosine acting via A1 receptors, controls the transition to status epilepticus-like behaviour in an in vitro model of epilepsy.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine Triphosphate; Analysis of Variance; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hippocampus; In Vitro Techniques; Rats; Rats, Wistar; Receptor, Adenosine A1; Status Epilepticus; Xanthines | 2004 |
Regulation by equilibrative nucleoside transporter of adenosine outward currents in adult rat spinal dorsal horn neurons.
Topics: 4-Aminopyridine; Adenosine; Animals; Barium; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Equilibrative Nucleoside Transport Proteins; Excitatory Postsynaptic Potentials; In Vitro Techniques; Male; Membrane Potentials; Patch-Clamp Techniques; Posterior Horn Cells; Potassium; Potassium Channel Blockers; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Substantia Gelatinosa; Xanthines | 2004 |
Allosteric modulation and constitutive activity of fusion proteins between the adenosine A1 receptor and different 351Cys-mutated Gi alpha-subunits.
Topics: Adenosine; Allosteric Site; Animals; Binding, Competitive; Cell Membrane; COS Cells; Cysteine; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Mutation; Radioligand Assay; Receptor, Adenosine A1; Recombinant Fusion Proteins; Sodium Chloride; Sulfur Radioisotopes; Thiophenes; Transfection; Tritium; Xanthines | 2004 |
Effects of adenosine on optic nerve head circulation in rabbits.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenosine A1 Receptor Antagonists; Adenylyl Cyclase Inhibitors; Animals; Caffeine; Capillaries; Dose-Response Relationship, Drug; Glyburide; Injections; Injections, Intravenous; Optic Disk; Phenethylamines; Potassium Channels; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rabbits; Regional Blood Flow; Stimulation, Chemical; Vasodilation; Vitreous Body; Xanthines | 2004 |
Modulating effect of adenosine deaminase on function of adenosine A1 receptors.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine Deaminase; Calcium; Cell Line; Cell Membrane; Embryo, Mammalian; Humans; Kidney; Radioligand Assay; Receptor, Adenosine A1; Signal Transduction; Xanthines | 2005 |
Reversal of neuromuscular effects of adenosine by specific adenosine A1-receptor antagonist in live rats.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Drug Interactions; Drug Synergism; Male; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Sciatic Nerve; Synaptic Transmission; Vecuronium Bromide; Xanthines | 2005 |
Activation of adenosine receptors in the posterior cingulate cortex impairs memory retrieval in the rat.
Topics: Adenosine; Animals; Avoidance Learning; Cerebral Cortex; Exploratory Behavior; Gyrus Cinguli; Male; Memory; Microinjections; Phenethylamines; Purinergic Agonists; Purinergic Antagonists; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Triazines; Triazoles; Xanthines | 2005 |
2-(1-Hexyn-1-yl)adenosine-induced intraocular hypertension is mediated via K+ channel opening through adenosine A2A receptor in rabbits.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Alkynes; Animals; Antihypertensive Agents; Caffeine; Decanoic Acids; Glyburide; Hydroxy Acids; Hypotonic Solutions; Intraocular Pressure; Male; Ocular Hypertension; Phenethylamines; Pinacidil; Potassium Channel Blockers; Potassium Channels; Rabbits; Receptor, Adenosine A2A; Sodium Chloride; Time Factors; Xanthines | 2005 |
Allosteric modulators affect the internalization of human adenosine A1 receptors.
Topics: Adenosine; Allosteric Regulation; Animals; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Endocytosis; Humans; Luminescent Proteins; Microscopy, Confocal; Radioligand Assay; Receptor, Adenosine A1; Recombinant Fusion Proteins; Thiadiazoles; Thiazoles; Thiophenes; Transfection; Tritium; Xanthines | 2005 |
Adenosine-stimulated atrial natriuretic peptide release through A1 receptor subtype.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Atrial Function; Atrial Natriuretic Factor; Colforsin; Cyclic AMP; Enzyme Inhibitors; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Xanthines | 2005 |
Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Allosteric Regulation; Animals; CHO Cells; Cricetinae; Cyclic AMP; Humans; Nitriles; Pyridines; Radioligand Assay; Receptor, Adenosine A1; Thermodynamics; Xanthines | 2006 |
Activation of adenosine A1 receptor modulates dopamine D1 receptor activity in stably cotransfected human embryonic kidney 293 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Alkaline Phosphatase; Benzazepines; Cell Line; Cyclic AMP Response Element-Binding Protein; DNA, Complementary; Dopamine Agonists; Dopamine Antagonists; Humans; Receptor, Adenosine A1; Receptors, Dopamine D1; Transfection; Xanthines | 2006 |
The enhancement of dopamine D1 receptor desensitization by adenosine A1 receptor activation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Binding, Competitive; Cell Line; Cyclic AMP; Dopamine Agonists; Drug Synergism; Humans; Receptor, Adenosine A1; Receptors, Dopamine D1; Time Factors; Transfection; Xanthines | 2007 |
ATP modulates the release of noradrenaline through two different prejunctional receptors on the adrenergic nerves of rat prostate.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Male; Norepinephrine; Presynaptic Terminals; Prostate; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptors, Presynaptic; Receptors, Purinergic P2; Suramin; Sympathetic Nervous System; Thionucleotides; Xanthines | 2007 |
Activation of the A1 adenosine receptor increases insulin-stimulated glucose transport in isolated rat soleus muscle.
Topics: 3-O-Methylglucose; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Biological Transport; Cell Membrane; Dose-Response Relationship, Drug; Glucose; Glucose Transporter Type 4; In Vitro Techniques; Insulin; Male; Muscle, Skeletal; Rats; Rats, Wistar; Receptor, Adenosine A1; RNA, Messenger; Xanthines | 2007 |
Influence of adenosine A(1)-receptor blockade and vagotomy on the gasping and heart rate response to hypoxia in rats during early postnatal maturation.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Animals, Newborn; Dose-Response Relationship, Drug; Forelimb; Heart Rate; Hypoxia; Parasympathetic Nervous System; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Reflex; Remission, Spontaneous; Vagotomy; Xanthines | 2007 |
A1 and A2A receptor activation by endogenous adenosine is required for VIP enhancement of K+ -evoked [3H]-GABA release from rat hippocampal nerve terminals.
Topics: Adenosine; Adenosine Deaminase; Animals; gamma-Aminobutyric Acid; Hippocampus; Male; Phenethylamines; Potassium; Presynaptic Terminals; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptors, Purinergic P1; Synaptic Transmission; Synaptosomes; Tritium; Vasoactive Intestinal Peptide; Xanthines | 2008 |
Adenosine modulates excitatory synaptic transmission and suppresses neuronal death induced by ischaemia in rat spinal motoneurones.
Topics: Adenosine; Animals; Cell Death; Excitatory Postsynaptic Potentials; In Vitro Techniques; Lumbar Vertebrae; Miniature Postsynaptic Potentials; Motor Neurons; Patch-Clamp Techniques; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptors, Presynaptic; Receptors, Purinergic P1; Sacrum; Spinal Cord; Spinal Cord Ischemia; Synaptic Transmission; Xanthines | 2008 |
Rhythm generation by the pre-Bötzinger complex in medullary slice and island preparations: effects of adenosine A(1) receptor activation.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Animals, Newborn; Bicuculline; Electrophysiology; Evoked Potentials; Female; In Vitro Techniques; Male; Medulla Oblongata; Mice; Neural Inhibition; Neurons; Patch-Clamp Techniques; Pyridazines; Receptor, Adenosine A1; Respiratory Center; Respiratory Mechanics; Strychnine; Synaptic Transmission; Xanthines | 2008 |
Adenosine modulates alpha2-adrenergic receptors within specific subnuclei of the nucleus tractus solitarius in normotensive and spontaneously hypertensive rats.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Intranuclear Space; Male; Protein Binding; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Adenosine A1; Receptors, Adrenergic, alpha-2; Solitary Nucleus; Xanthines | 2008 |
The potential role of the nodose ganglion adenosine A1 receptor in regulation of breathing in anaesthetized rats.
Topics: Adenosine; Animals; Blood Pressure; Heart Rate; Male; Nodose Ganglion; Rats; Rats, Wistar; Receptor, Adenosine A1; Respiratory Mechanics; Tidal Volume; Vagotomy; Xanthines | 2008 |
Cardioprotection induced by adenosine A1 receptor agonists in a cardiac cell ischemia model involves cooperative activation of adenosine A2A and A2B receptors by endogenous adenosine.
Topics: Acetamides; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Aminopyridines; Animals; Apoptosis; Cardiotonic Agents; Cell Line; Cell Survival; Dihydropyridines; Imidazoles; Myocardial Ischemia; Phenethylamines; Purines; Rats; Triazines; Triazoles; Xanthines | 2009 |
Adenosine A1 receptors presynaptically modulate excitatory synaptic input onto subiculum neurons.
Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Central Nervous System Agents; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Membrane Potentials; Neurons; Presynaptic Terminals; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Adenosine A2; Synapses; Synaptic Transmission; Triazines; Triazoles; Xanthines | 2009 |
P2X(1) receptor blockade inhibits whole kidney autoregulation of renal blood flow in vivo.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine Triphosphate; Animals; Arterioles; Blood Pressure; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Homeostasis; Kidney; Male; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Purinergic P2; Receptors, Purinergic P2X; Renal Circulation; Xanthines | 2010 |
Differential effects of adenosine A1 receptor on pain-related behavior in normal and nerve-injured rats.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Drug Administration Schedule; Electric Stimulation; Electrophysiology; Escape Reaction; Injections, Intraperitoneal; Long-Term Potentiation; Male; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Neuralgia; Pain Threshold; Rats; Rats, Sprague-Dawley; Spinal Nerves; Xanthines | 2010 |
Cooperative cardioprotection through adenosine A1 and A2A receptor agonism in ischemia-reperfused isolated mouse heart.
Topics: Acetamides; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Blood Pressure; Cardiotonic Agents; Drug Synergism; In Vitro Techniques; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Contraction; Myocardial Reperfusion Injury; Phosphorylation; Purines; Receptor, Adenosine A2A; Triazines; Triazoles; Xanthines | 2010 |
A1 receptors self-regulate adenosine release in the striatum: evidence of autoreceptor characteristics.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Analysis of Variance; Animals; Benzazepines; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Interactions; Electric Stimulation; Electrochemistry; Electrodes, Implanted; Male; Models, Biological; Neural Pathways; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Substantia Nigra; Time Factors; Ventral Tegmental Area; Xanthines | 2010 |
Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions.
Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Dose-Response Relationship, Drug; Equilibrative Nucleoside Transporter 1; Female; Glucose; Glutathione; Hippocampus; Humans; Hypoxia; In Vitro Techniques; Mice; Mice, Transgenic; Neurons; Patch-Clamp Techniques; Protein Binding; Purinergic P1 Receptor Agonists; Statistics, Nonparametric; Synaptic Transmission; Thioinosine; Tritium; Xanthines | 2011 |
Genetically controlled upregulation of adenosine A(1) receptor expression enhances the survival of primary cortical neurons.
Topics: Adenosine; Adenosine Deaminase; Animals; Calcium Channels; Cell Survival; Cerebral Cortex; HEK293 Cells; Humans; Mice; N-Methylaspartate; Neurons; Neuroprotective Agents; Neurotoxins; Receptor, Adenosine A1; Tetracycline; Transfection; Up-Regulation; Xanthines | 2012 |
NeuroProtective effects of adenosine receptor agonist coadministration with ascorbic acid on CA1 hippocampus in a mouse model of ischemia reperfusion injury.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Antioxidants; Ascorbic Acid; Avoidance Learning; bcl-2-Associated X Protein; Behavior, Animal; Blotting, Western; CA1 Region, Hippocampal; In Situ Nick-End Labeling; Male; Maze Learning; Memory, Short-Term; Mice; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Receptors, Purinergic P1; Reperfusion Injury; Xanthines | 2013 |
Modulation of cGMP accumulation by adenosine A1 receptors at the hippocampus: influence of cGMP levels and gender.
Topics: Adenosine; Adenosine Deaminase; Animals; Colforsin; Cyclic AMP; Cyclic GMP; Female; Hippocampus; Imidazoles; Male; Nitroprusside; Rats; Rats, Wistar; Receptor, Adenosine A1; Rolipram; Triazines; Xanthines | 2014 |
Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Amyotrophic Lateral Sclerosis; Animals; Evoked Potentials; Mice; Motor Endplate; Neuromuscular Junction; Phenethylamines; Receptor Cross-Talk; Receptor, Adenosine A1; Receptor, Adenosine A2A; Superoxide Dismutase; Superoxide Dismutase-1; Synaptic Transmission; Xanthines | 2015 |
Adenosine A1 receptors mediate the intracisternal injection of orexin-induced antinociceptive action against colonic distension in conscious rats.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Analgesics; Animals; Colon; Consciousness; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Male; Orexins; Physical Stimulation; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Reflex; Visceral Pain; Xanthines | 2016 |
Adenosine A1 receptor modifies P53 expression and apoptosis in breast cancer cell line Mcf-7.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Gene Expression Profiling; Genes, p53; Humans; MCF-7 Cells; Receptor, Adenosine A1; Xanthines | 2016 |